Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Debt to Equity: 2024-2025

Historic Debt to Equity for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $0.04.

  • Kura Oncology's Debt to Equity rose 78.43% to $0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.04, marking a year-over-year increase of 78.43%. This contributed to the annual value of $0.02 for FY2024, which is N/A change from last year.
  • Latest data reveals that Kura Oncology reported Debt to Equity of $0.04 as of Q3 2025, which was up 26.63% from $0.03 recorded in Q2 2025.
  • Kura Oncology's 5-year Debt to Equity high stood at $0.04 for Q3 2025, and its period low was $0.02 during Q1 2024.
  • Over the past 2 years, Kura Oncology's median Debt to Equity value was $0.02 (recorded in 2024), while the average stood at $0.03.
  • Data for Kura Oncology's Debt to Equity shows a peak YoY surged of 78.43% (in 2025) over the last 5 years.
  • Over the past 2 years, Kura Oncology's Debt to Equity (Quarterly) stood at $0.02 in 2024, then skyrocketed by 78.43% to $0.04 in 2025.
  • Its Debt to Equity stands at $0.04 for Q3 2025, versus $0.03 for Q2 2025 and $0.03 for Q1 2025.